| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |